This website is for UK Healthcare Professionals only

This promotional material is intended for UK Healthcare Professionals only.
BOTOX® (botulinum toxin type A) Prescribing Information and adverse event reporting information can be found below.

 

Contact us

Please complete the form below and a member of the BOTOX® (botulinum toxin type A) team will get back to you.

Please fill in your details below only if you are a UK registered healthcare professional and would like to be contacted by an AbbVie representative.

BOTOX® is indicated for the symptomatic treatment of focal spasticity, including:1

  • upper limb spasticity in adults 
  • ankle and foot disability due to lower limb spasticity in adults

The BOTOX® (botulinum toxin type A) prescribing information and adverse event reporting information can be found at the bottom of the page. 

Please enter First name
Please enter Last name
E-mail address is not valid
Please enter Hospital name
Please enter Hospital postcode

Please select the items you are interested in:

Please select one field.
Please select one field.


Please refer to the AbbVie privacy notice here for more information on how AbbVie processes your personal data and your data privacy rights.

*Denotes mandatory field

Incorrect. Please try again.

 

References

1. BOTOX® Summary of Product Characteristics. Available from: www.medicines.org.uk.

 

Please refer to the BOTOX® Summary of Product Characteristics for further information on adverse events, contraindications and special warnings and precautions for use. The BOTOX® Summary of Product Characteristics can be found here

By clicking the link above you will leave the AbbVie Pro website and be taken to the eMC PI portal website.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores.

Adverse events should also be reported to AbbVie on GBPV@abbvie.com

 

Date of preparation: June 2025. UK-BTX-250039.